Home › Inborn Errors Metabolism › Pennsylvania › Philadelphia
Inborn Errors Metabolism clinical trials in Philadelphia, PA
4 studies for Inborn Errors Metabolism are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
RecruitingPhase 1/2
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
RecruitingEarly phase 1
- Children's Hospital of Philadelphia, Philadelphia
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
RecruitingPhase 1/2
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Inborn Errors Metabolism trials in other cities
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.